Orazio Caffo, MD, director of medical oncology at the Santa Chiara Hospital in Trento, Italy, discusses enzalutamide plus docetaxel combination for the frontline treatment of metastatic castration-resistant prostate cancer.
Orazio Caffo, MD
Advertisement
Articles by Orazio Caffo, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Elfetabart Drozuntecan Elicits 70% ORR Across Lines of Therapy in SCLC
2
SERENA-4 Misses Primary PFS End Point With Camizestrant Plus Palbociclib in First-Line ER+ Advanced Breast Cancer
3
FDA Extends Review Period for Zanzalintinib Plus Atezolizumab NDA in Pretreated mCRC
4
Dibotatug Is Safe and Yields Durable Responses in Large Granular Lymphocytic Leukemia
5